Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Daiichi Sankyo
Chinese Patent Office

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,034,324

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,034,324
Title:Anti-BCMA antibodies
Abstract: This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naive B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naive B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases.
Inventor(s): Kalled; Susan L. (Concord, MA), Hsu; Yen-Ming (Lexington, MA)
Assignee: BIOGEN IDEC MA INC. (Cambridge, MA)
Application Number:13/255,610
Patent Claims:see list of patent claims

Details for Patent 9,034,324

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial BIOGEN IDEC MA INC. (Cambridge, MA) 2029-03-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.